{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T07:34:15Z","timestamp":1780817655351,"version":"3.54.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1007\/s10815-009-9332-8","type":"journal-article","created":{"date-parts":[[2009,9,18]],"date-time":"2009-09-18T06:02:45Z","timestamp":1253253765000},"page":"383-389","source":"Crossref","is-referenced-by-count":52,"title":["Serum anti-M\u00fcllerian hormone predicts ovarian response and cycle outcome in IVF patients"],"prefix":"10.1007","volume":"26","author":[{"given":"Cheng-Hsuan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ching","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Hung","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyuer-Ger","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horng-Der","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,9,19]]},"reference":[{"key":"9332_CR1","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1093\/humrep\/15.11.2297","volume":"15","author":"A Ravhon","year":"2000","unstructured":"Ravhon A, Lavery S, Michael S, Donaldson M, Margara R, Trew G, et al. Dynamic assays of inhibin B and oestradiol following buserelin acetate administration as predictors of ovarian response in IVF. Hum Reprod. 2000;15:2297\u2013301.","journal-title":"Hum Reprod"},{"key":"9332_CR2","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0015-0282(01)02983-1","volume":"77","author":"LF Bancsi","year":"2002","unstructured":"Bancsi LF, Broekmans FJ, Eijkemans MJ, de Jong FH, Habbema JD, te Velde ER. Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve. Fertil Steril. 2002;77:328\u201336.","journal-title":"Fertil Steril"},{"key":"9332_CR3","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/humupd\/dml034","volume":"12","author":"FJ Broekmans","year":"2006","unstructured":"Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Updat. 2006;12:685\u2013718.","journal-title":"Hum Reprod Updat"},{"key":"9332_CR4","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/humrep\/12.2.294","volume":"12","author":"A Lass","year":"1997","unstructured":"Lass A, Skull J, McVeigh E, Margara R, Winston RM. Measurement of ovarian volume by transvaginal sonography before ovulation induction with human menopausal gonadotrophin for in-vitro fertilization can predict poor response. Hum Reprod. 1997;12:294\u20137.","journal-title":"Hum Reprod"},{"key":"9332_CR5","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/humrep\/deh285","volume":"19","author":"WH Wallace","year":"2004","unstructured":"Wallace WH, Kelsey TW. Ovarian reserve and reproductive age may be determined from measurement of ovarian volume by transvaginal sonography. Hum Reprod. 2004;19:1612\u20137.","journal-title":"Hum Reprod"},{"key":"9332_CR6","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0015-0282(97)00557-8","volume":"69","author":"MY Chang","year":"1998","unstructured":"Chang MY, Chiang CH, Hsieh TT, Soong YK, Hsu KH. Use of the antral follicle count to predict the outcome of assisted reproductive technologies. Fertil Steril. 1998;69:505\u201310.","journal-title":"Fertil Steril"},{"key":"9332_CR7","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.fertnstert.2004.10.011","volume":"83","author":"DJ Hendriks","year":"2005","unstructured":"Hendriks DJ, Mol BW, Bancsi LF, Te Velde ER, Broekmans FJ. Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: a meta-analysis and comparison with basal follicle-stimulating hormone level. Fertil Steril. 2005;83:291\u2013301.","journal-title":"Fertil Steril"},{"key":"9332_CR8","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/j.1471-0528.2005.00670.x","volume":"112","author":"S Muttukrishna","year":"2005","unstructured":"Muttukrishna S, McGarrigle H, Wakim R, Khadum I, Ranieri DM, Serhal P. Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology? BJOG. 2005;112:1384\u201390.","journal-title":"BJOG"},{"key":"9332_CR9","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0015-0282(01)03201-0","volume":"77","author":"DB Seifer","year":"2002","unstructured":"Seifer DB, MacLaughlin DT, Christian BP, Feng B, Shelden RM. Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril. 2002;77:468\u201371.","journal-title":"Fertil Steril"},{"key":"9332_CR10","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1093\/humrep\/17.12.3065","volume":"17","author":"IA Rooij Van","year":"2002","unstructured":"Van Rooij IA, Broekmans FJM, te Velde ER, Fauser BCJM, Bancsi LFJMM, de Jong FH, et al. Serum anti-M\u00fcllerian hormone levels: a novel measure of ovarian reserve. Hum Reprod. 2002;17:3065\u201371.","journal-title":"Hum Reprod"},{"key":"9332_CR11","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/humrep\/deg042","volume":"18","author":"R Fanchin","year":"2003","unstructured":"Fanchin R, Schonauer LM, Righini C, Guibourdenche J, Frydman R, Taieb J. Serum anti-M\u00fcllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod. 2003;18:323\u20137.","journal-title":"Hum Reprod"},{"key":"9332_CR12","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.fertnstert.2004.03.061","volume":"82","author":"A Hazout","year":"2004","unstructured":"Hazout A, Bouchard P, Seifer DB, Aussage P, Junca AM, Cohen-Bacrie P. Serum antimullerian hormone\/mullerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol. Fertil Steril. 2004;82:1323\u20139.","journal-title":"Fertil Steril"},{"key":"9332_CR13","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1093\/humrep\/dei203","volume":"20","author":"T Eldar-Geva","year":"2005","unstructured":"Eldar-Geva T, Ben-Chetrit A, Spitz IM, Rabinowitz R, Markowitz E, Mimoni T, et al. Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome. Hum Reprod. 2005;20:3178\u201383.","journal-title":"Hum Reprod"},{"key":"9332_CR14","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/humrep\/deh718","volume":"20","author":"J Penarrubia","year":"2005","unstructured":"Penarrubia J, Fabregues F, Manau D, Creus M, Casals G, Casamitjana R, et al. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist\u2013gonadotropin treatment. Hum Reprod. 2005;20:915\u201322.","journal-title":"Hum Reprod"},{"key":"9332_CR15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1479-828X.2005.00332.x","volume":"45","author":"KP Tremellen","year":"2005","unstructured":"Tremellen KP, Kolo M, Gilmore A, Lekamge DN. Anti-mullerian hormone as a marker of ovarian reserve. Aust NZ J Obstet Gynaecol. 2005;45:20\u20134.","journal-title":"Aust NZ J Obstet Gynaecol"},{"key":"9332_CR16","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.fertnstert.2005.09.019","volume":"85","author":"C Fi\u00e7icioglu","year":"2006","unstructured":"Fi\u00e7icioglu C, Kutlu T, Baglam E, Bakacak Z. Early follicular antim\u00fcllerian hormone as an indicator of ovarian reserve. Fertil Steril. 2006;85:592\u20136.","journal-title":"Fertil Steril"},{"key":"9332_CR17","first-page":"571","volume":"81","author":"MM Lee","year":"1996","unstructured":"Lee MM, Donahoe PK, Hasegawa T, Silverman B, Crist GB, Best S, et al. M\u00fcllerian inhibiting substance in humans: normal levels from infancy to adulthood. J Clin Endocrinol Metab. 1996;81:571\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"9332_CR18","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1530\/rep.0.1240601","volume":"124","author":"AL Durlinger","year":"2002","unstructured":"Durlinger AL, Visser JA. Themmen AP Regulation of ovarian function: the role of anti-Mullerian hormone. Reproduction. 2002;124:601\u20139.","journal-title":"Reproduction"},{"key":"9332_CR19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/molehr\/gah015","volume":"10","author":"C Weenen","year":"2004","unstructured":"Weenen C, Laven JS, Von Bergh AR, Cranfield M, Groome NP, Visser JA, et al. Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod. 2004;10:77\u201383.","journal-title":"Mol Hum Reprod"},{"key":"9332_CR20","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0015-0282(01)02993-4","volume":"77","author":"A Vet De","year":"2002","unstructured":"De Vet A, Laven JS, de Jong FH, Themmen AP, Fauser BC. Anti-mullerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril. 2002;77:357\u201362.","journal-title":"Fertil Steril"},{"key":"9332_CR21","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/humrep\/deh688","volume":"20","author":"R Fanchin","year":"2005","unstructured":"Fanchin R, Taieb J, Lozano DH, Ducot B, Frydman R, Bouyer J. High reproducibility of serum anti-Mullerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status. Hum Reprod. 2005;20:923\u20137.","journal-title":"Hum Reprod"},{"key":"9332_CR22","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S1472-6483(10)61053-X","volume":"14","author":"DN Lekamge","year":"2007","unstructured":"Lekamge DN, Barry M, Kolo M, Lane M, Gilchrist RB, Tremellen KP. Anti-M\u00fcllerian hormone as a predictor of IVF outcome. Reprod Biomed Online. 2007;14:602\u201310.","journal-title":"Reprod Biomed Online"},{"key":"9332_CR23","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/j.fertnstert.2007.10.078","volume":"90","author":"DM Wunder","year":"2008","unstructured":"Wunder DM, Guibourdenche J, Birkh\u00e4user MH, Bersinger NA. Anti-M\u00fcllerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization\/intracytoplasmic sperm injection. Fertil Steril. 2008;90:2203\u201310.","journal-title":"Fertil Steril"},{"key":"9332_CR24","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.fertnstert.2008.09.069","volume":"91","author":"DH Barad","year":"2009","unstructured":"Barad DH, Weghofer A, Gleicher N. Comparing anti-M\u00fcllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function. Fertil Steril. 2009;91:1553\u20135.","journal-title":"Fertil Steril"},{"key":"9332_CR25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.fertnstert.2006.06.019","volume":"87","author":"JM Smeenk","year":"2007","unstructured":"Smeenk JM, Sweep FC, Zielhuis GA, Kremer JA, Thomas CM, Braat DD. Antim\u00fcllerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injection. Fertil Steril. 2007;87:223\u20136.","journal-title":"Fertil Steril"},{"key":"9332_CR26","first-page":"160","volume":"23","author":"TH Lee","year":"2008","unstructured":"Lee TH, Liu CH, Huang CC, Wu YL, Shih YT, Ho HN, et al. Serum anti-mullerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles. Hum Reprod. 2008;23:160\u20137.","journal-title":"Hum Reprod"},{"key":"9332_CR27","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1028-4559(08)60057-1","volume":"47","author":"YY Hsieh","year":"2008","unstructured":"Hsieh YY, Chang CC, Tsai HD. Comparisons of different dosages of gonadotropin-releasing hormone (GnRH) antagonist, short-acting form and single, half-dose, long-acting form of GnRH agonist during controlled ovarian hyperstimulation and in vitro fertilization. Taiwan J Obstet Gynecol. 2008;47:66\u201374.","journal-title":"Taiwan J Obstet Gynecol"},{"key":"9332_CR28","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S1472-6483(10)60835-8","volume":"11","author":"A Borini","year":"2005","unstructured":"Borini A, Dal Prato L. Tailoring FSH and LH administration to individual patients. Reprod Biomed Online. 2005;11:283\u201393.","journal-title":"Reprod Biomed Online"},{"key":"9332_CR29","doi-asserted-by":"crossref","first-page":"202.e1","DOI":"10.1016\/j.ajog.2008.05.004","volume":"199","author":"RM Riggs","year":"2008","unstructured":"Riggs RM, Duran EH, Baker MW, Kimble TD, Hobeika E, Yin L, et al. Assessment of ovarian reserve with anti-M\u00fcllerian hormone: a comparison of the predictive value of anti-M\u00fcllerian hormone, follicle-stimulating hormone, inhibin B, and age. Am J Obstet Gynecol. 2008;199:202.e1\u20138.","journal-title":"Am J Obstet Gynecol"},{"key":"9332_CR30","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1016\/j.fertnstert.2008.03.034","volume":"91","author":"T Singer","year":"2009","unstructured":"Singer T, Barad DH, Weghofer A, Gleicher N. Correlation of antim\u00fcllerian hormone and baseline follicle-stimulating hormone levels. Fertil Steril. 2009;91:2616\u20139.","journal-title":"Fertil Steril"},{"key":"9332_CR31","doi-asserted-by":"crossref","unstructured":"Nardo LG, Gelbaya TA, Wilkinson H, Roberts SA, Yates A, Pemberton P, Laing I. Circulating basal anti-M\u00fcllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.Fertil Steril. 2008 Oct 16. [Epub ahead of print].","DOI":"10.1016\/j.fertnstert.2008.08.127"},{"key":"9332_CR32","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/humrep\/dei270","volume":"21","author":"T Silberstein","year":"2006","unstructured":"Silberstein T, MacLaughlin DT, Shai I, Trimarchi JR, Lambert-Messerlian G, Seifer DB, et al. Mullerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology. Hum Reprod. 2006;21:159\u201363.","journal-title":"Hum Reprod"},{"key":"9332_CR33","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3346\/jkms.2008.23.4.657","volume":"23","author":"BC Jee","year":"2008","unstructured":"Jee BC, Ku SY, Suh CS, Kim KC, Lee WD, Kim SH. Serum anti-M\u00fcllerian hormone and inhibin B levels at ovulation triggering day can predict the number of immature oocytes retrieved in in vitro fertilization cycles. J Korean Med Sci. 2008;23:657\u201361.","journal-title":"J Korean Med Sci."},{"key":"9332_CR34","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1210\/jc.2003-030932","volume":"89","author":"JS Laven","year":"2004","unstructured":"Laven JS, Mulders AG, Visser JA, Themmen AP, De Jong FH, Fauser BCJM. Antim\u00fcllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab. 2004;89:318\u201323.","journal-title":"J Clin Endocrinol Metab"},{"key":"9332_CR35","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1093\/humrep\/deh508","volume":"19","author":"A Marca La","year":"2004","unstructured":"La Marca A, Malmusi S, Giulini S, Tamaro LF, Orvieto R, Levratti P, et al. Anti-Mullerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation. Hum Reprod. 2004;19:2738\u201341.","journal-title":"Hum Reprod"},{"key":"9332_CR36","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S1472-6483(10)61081-4","volume":"12","author":"E Feyereisen","year":"2006","unstructured":"Feyereisen E, Mendez DH, Taieb J, et al. Anti-M\u00fcllerian hormone: clinical insights into a promising biomarker of the ovarian follicular status. Reprod Biomed Online. 2006;12:695\u2013703.","journal-title":"Reprod Biomed Online"},{"key":"9332_CR37","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S1472-6483(10)60480-4","volume":"16","author":"S Lie Fong","year":"2008","unstructured":"Lie Fong S, Baart EB, Martini E, Schipper I, Visser JA, Themmen AP, et al. Anti-M\u00fcllerian hormone: a marker for oocyte quantity, oocyte quality and embryo quality? Reprod Biomed Online. 2008;16:664\u201370.","journal-title":"Reprod Biomed Online"},{"key":"9332_CR38","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ejogrb.2007.01.012","volume":"134","author":"A Somunkiran","year":"2007","unstructured":"Somunkiran A, Yavuz T, Yucel O, Ozdemir I. Anti-Mullerian hormone levels during hormonal contraception in women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2007;134:196\u2013201.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"9332_CR39","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1093\/humrep\/dem258","volume":"22","author":"E Arbo","year":"2007","unstructured":"Arbo E, Vetori DV, Jimenez MF, Freitas FM, Lemos N, Cunha-Filho JS. Serum anti-Mullerian hormone levels and follicular cohort characteristics after pituitary suppression in the late luteal phase with oral contraceptive pills. Hum Reprod. 2007;22:3192\u20136.","journal-title":"Hum Reprod"},{"key":"9332_CR40","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.fertnstert.2006.03.047","volume":"86","author":"KA Mohamed","year":"2006","unstructured":"Mohamed KA, DaviesWA LH. Antimullerian hormone and pituitary gland activity after prolonged down-regulation with goserelin acetate. Fertil Steril. 2006;86:1515\u20137.","journal-title":"Fertil Steril"},{"key":"9332_CR41","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/humrep\/deh819","volume":"20","author":"A Marca La","year":"2005","unstructured":"La Marca A, Giulini S, Orvieto R, De Leo V, Volpe A. Anti-Mullerian hormone concentrations in maternal serum during pregnancy. Hum Reprod. 2005;20:1569\u201372.","journal-title":"Hum Reprod"},{"key":"9332_CR42","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1210\/jc.2006-0331","volume":"91","author":"WJ Hehenkamp","year":"2006","unstructured":"Hehenkamp WJ, Looman CW, Themmen APN, de Jong FH, Te Velde ER, Broekmans FJ. Anti-Mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. J Clin Endocrinol Metab. 2006;91:4057\u201363.","journal-title":"J Clin Endocrinol Metab"},{"key":"9332_CR43","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1093\/humrep\/del291","volume":"21","author":"A Marca La","year":"2006","unstructured":"La Marca A, Stabile G, Carducci Artenisio A, Volpe A. Serum antimullerian hormone throughout the human menstrual cycle. Hum Reprod. 2006;21:3103\u20137.","journal-title":"Hum Reprod"},{"key":"9332_CR44","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1093\/humrep\/dem101","volume":"22","author":"S Tsepelidis","year":"2007","unstructured":"Tsepelidis S, Devreker F, Demeestere I, Flahaut A, Gervy Ch, Englert Y. Stable serum levels of anti-M\u00fcllerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women. Hum Reprod. 2007;22:1837\u201340.","journal-title":"Hum Reprod"},{"key":"9332_CR45","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.fertnstert.2007.06.023","volume":"90","author":"I Streuli","year":"2008","unstructured":"Streuli I, Fraisse T, Pillet C, Ibecheole V, Bischof P, de Ziegler D. Serum antim\u00fcllerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids. Fertil Steril. 2008;90:395\u2013400.","journal-title":"Fertil Steril"},{"issue":"Suppl","key":"9332_CR46","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.fertnstert.2006.07.030","volume":"86","author":"N Lahlou","year":"2006","unstructured":"Lahlou N, Chabbert-Buffet N, Gainer E, Roger M, Bouchard P, VA2914 Study Group. Diphasic pattern of anti-mullerian hormone (AMH) in ovulatory cycles as evidenced by means of an ultra-sensitive assay: new insights into ovarian function. Fertil Steril. 2006;86(Suppl):S11.","journal-title":"Fertil Steril"},{"key":"9332_CR47","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.fertnstert.2007.04.054","volume":"89","author":"DM Wunder","year":"2008","unstructured":"Wunder DM, Bersinger NA, Yared M, Kretschmer R, Birkh\u00e4user MH. Statistically significant changes of antim\u00fcllerian hormone and inhibin levels during the physiologic menstrual cycle in reproductive age women. Fertil Steril. 2008;89:927\u201333.","journal-title":"Fertil Steril"},{"key":"9332_CR48","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cca.2006.06.013","volume":"375","author":"T Freour","year":"2007","unstructured":"Freour T, Miralli\u00e9 S, Bach-Ngohou K, Denis M, Barri\u00e8re P, Masson D. Measurement of serum anti-M\u00fcllerian hormone by Beckman Coulter ELISA and DSL ELISA: comparison and relevance in assisted reproduction technology (ART). Clin Chim Acta. 2007;375:162\u20134.","journal-title":"Clin Chim Acta"},{"key":"9332_CR49","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.fertnstert.2007.10.067","volume":"91","author":"I Streuli","year":"2009","unstructured":"Streuli I, Fraisse T, Chapron C, Bijaoui G, Bischof P, de Ziegler D. Clinical uses of anti-M\u00fcllerian hormone assays: pitfalls and promises. Fertil Steril. 2009;91:226\u201330.","journal-title":"Fertil Steril"},{"key":"9332_CR50","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1210\/jc.2008-1818","volume":"94","author":"EA Knauff","year":"2009","unstructured":"Knauff EA, Eijkemans MJ, Lambalk CB, Broekmans FJ, Themmen AP, Fauser BC. Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure. J Clin Endocrinol Metab. 2009;94:786\u201392.","journal-title":"J Clin Endocrinol Metab"},{"key":"9332_CR51","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s10815-008-9266-6","volume":"25","author":"DN Lekamge","year":"2008","unstructured":"Lekamge DN, Lane M, Gilchrist RB, Tremellen KP. Increased gonadotrophin stimulation does not improve IVF outcomes in patients with predicted poor ovarian reserve. J Assist Reprod Genet. 2008;25:515\u201321.","journal-title":"J Assist Reprod Genet"},{"key":"9332_CR52","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/humrep\/del435","volume":"22","author":"M McIlveen","year":"2007","unstructured":"McIlveen M, Skull JD, Ledger WL. Evaluation of the utility of multiple endocrine and ultrasound measures of ovarian reserve in the prediction of cycle cancellation in a high-risk IVF population. Hum Reprod. 2007;22:778\u20138.","journal-title":"Hum Reprod"},{"key":"9332_CR53","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/humrep\/den108","volume":"23","author":"C Gnoth","year":"2008","unstructured":"Gnoth C, Schuring AN, Friol K, Tigges J, Mallmann P, Godehardt E. Relevance of anti-Mullerian hormone measurement in a routine IVF program. Hum Reprod. 2008;23:1359\u201365.","journal-title":"Hum Reprod"},{"key":"9332_CR54","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.fertnstert.2007.12.013","volume":"91","author":"SL Broer","year":"2009","unstructured":"Broer SL, Mol BW, Hendriks D, Broekmans FJ. The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertil Steril. 2009;91:705\u201314.","journal-title":"Fertil Steril"},{"key":"9332_CR55","unstructured":"Jayaprakasan K, Campbell B, Hopkisson J, Johnson I, Raine-Fenning N. A prospective, comparative analysis of anti-M\u00fcllerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation. Fertil Steril. 2008; Nov 29. [Epub ahead of print]."},{"key":"9332_CR56","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.fertnstert.2006.11.006","volume":"87","author":"DJ Hendricks","year":"2007","unstructured":"Hendricks DJ, Kwee J, et al. Ultrasonography as a tool for the prediction of outcome in IVF patients: a comparative metaanalysis of ovarian volume and antral follicle count. Fertil Steril. 2007;87:764\u201375.","journal-title":"Fertil Steril"},{"key":"9332_CR57","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.fertnstert.2007.05.040","volume":"89","author":"EA Elgindy","year":"2008","unstructured":"Elgindy EA, El-Haieg DO, El-Sebaey A. Anti-M\u00fcllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients. Fertil Steril. 2008;89:1670\u20136.","journal-title":"Fertil Steril"},{"key":"9332_CR58","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1093\/humrep\/del127","volume":"21","author":"T Ebner","year":"2006","unstructured":"Ebner T, Sommergruber M, Moser M, Shebl O, Schreier-Lechner E, Tews G. Basal level of anti-Mullerian hormone is associated with oocyte quality in stimulated cycles. Hum Reprod. 2006;21:2022\u20136.","journal-title":"Hum Reprod"},{"key":"9332_CR59","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1093\/humrep\/dem204","volume":"22","author":"SM Nelson","year":"2007","unstructured":"Nelson SM, Yates RW, Fleming R. Serum anti-M\u00fcllerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles\u2014implications for individualization of therapy. Hum Reprod. 2007;22:2414\u201321.","journal-title":"Hum Reprod"},{"key":"9332_CR60","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/humrep\/den480","volume":"24","author":"SM Nelson","year":"2009","unstructured":"Nelson SM, Yates RW, Lyall H, Jamieson M, Traynor I, Gaudoin M, et al. Anti-Mullerian hormone-based approach to controlled ovarian stimulation for assisted conception. Hum Reprod. 2009;24:867\u201375.","journal-title":"Hum Reprod"},{"key":"9332_CR61","doi-asserted-by":"crossref","unstructured":"La Marca A, Broekmans FJ, Volpe A, Fauser BC, Macklon NS; on behalf of the ESHRE Special Interest Group for Reproductive Endocrinology \u2013 AMH Round Table. Anti-Mullerian hormone (AMH): what do we still need to know? Hum Reprod. 2009 Jun 11. [Epub ahead of print].","DOI":"10.1093\/humrep\/dep210"}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-009-9332-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10815-009-9332-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-009-9332-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T01:15:50Z","timestamp":1559265350000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10815-009-9332-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":61,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["9332"],"URL":"https:\/\/doi.org\/10.1007\/s10815-009-9332-8","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"value":"1058-0468","type":"print"},{"value":"1573-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}